3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate Cancer
Imaging of the Prostate Gland Using High Field Strength 3T MRI
Sponsor: University of Cincinnati
This NA trial investigates Prostate Cancer and is currently ongoing. University of Cincinnati leads this study, which shows 13 recorded versions since 2007 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
13 versions recorded-
May 2025 — Present [monthly]
Active Not Recruiting NA
-
Sep 2024 — May 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Feb 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
-
Mar 2023 — Feb 2024 [monthly]
Active Not Recruiting NA
▶ Show 8 earlier versions
-
Dec 2022 — Mar 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
May 2022 — Dec 2022 [monthly]
Recruiting NA
-
Sep 2021 — May 2022 [monthly]
Recruiting NA
-
Jan 2021 — Sep 2021 [monthly]
Recruiting NA
-
Apr 2019 — Jan 2021 [monthly]
Recruiting NA
-
Jun 2018 — Apr 2019 [monthly]
Recruiting NA
-
Oct 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Unknown Status → Recruiting
-
Jan 2017 — Oct 2017 [monthly]
Unknown Status NA
First recorded
Sep 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Cincinnati
For direct contact, visit the study record on ClinicalTrials.gov .